Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Aldose Reductase Acts as a Selective Derepressor of PPARγ and the Retinoic Acid Receptor.

Cell reports | 2016

Histone deacetylase 3 (HDAC3), a chromatin-modifying enzyme, requires association with the deacetylase-containing domain (DAD) of the nuclear receptor corepressors NCOR1 and SMRT for its stability and activity. Here, we show that aldose reductase (AR), the rate-limiting enzyme of the polyol pathway, competes with HDAC3 to bind the NCOR1/SMRT DAD. Increased AR expression leads to HDAC3 degradation followed by increased PPARγ signaling, resulting in lipid accumulation in the heart. AR also downregulates expression of nuclear corepressor complex cofactors including Gps2 and Tblr1, thus affecting activity of the nuclear corepressor complex itself. Though AR reduces HDAC3-corepressor complex formation, it specifically derepresses the retinoic acid receptor (RAR), but not other nuclear receptors such as the thyroid receptor (TR) and liver X receptor (LXR). In summary, this work defines a distinct role for AR in lipid and retinoid metabolism through HDAC3 regulation and consequent derepression of PPARγ and RAR.

Pubmed ID: 27052179 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL060901
  • Agency: NIA NIH HHS, United States
    Id: AG026467
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK020572
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK081943
  • Agency: NHLBI NIH HHS, United States
    Id: HL102022
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL102022
  • Agency: NHLBI NIH HHS, United States
    Id: HL60901
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK020541
  • Agency: NHLBI NIH HHS, United States
    Id: HL61783
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL061783
  • Agency: NIA NIH HHS, United States
    Id: P01 AG026467

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Vector BioLabs (tool)

RRID:SCR_011010

Biotechnology company focused on developing robust gene delivery products, by using its proprietary technologies. Since 2004, we have worked with over 300 research labs in 20 different countries to provide gene delivery products and services using many viral platforms including recombinant adenoviruses, adeno-associated virus (AAV) and lentivirus.

View all literature mentions